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Demyelinating disorders including leukodystrophies are devastat-
ing conditions that are still in need of better understanding, and
both oligodendrocyte differentiation and myelin synthesis path-
ways are potential avenues for developing treatment. Overex-
pression of lamin B1 leads to leukodystrophy characterized by
demyelination of the central nervous system, and microRNA-23
(miR-23) was found to suppress lamin B1 and enhance oligoden-
drocyte differentiation in vitro. Here, we demonstrated that miR-
23a–overexpressing mice have increased myelin thickness, provid-
ing in vivo evidence that miR-23a enhances both oligodendrocyte
differentiation and myelin synthesis. Using this mouse model, we
explored possible miR-23a targets and revealed that the phospha-
tase and tensin homologue/phosphatidylinositol trisphosphate ki-
nase/Akt/mammalian target of rapamycin pathway is modulated
by miR-23a. Additionally, a long noncoding RNA, 2700046G09Rik,
was identified as a miR-23a target and modulates phosphatase
and tensin homologue itself in a miR-23a–dependent manner.
The data presented here imply a unique role for miR-23a in the
coordination of proteins and noncoding RNAs in generating and
maintaining healthy myelin.
MicroRNAs (miRNAs) play an important role in regulatinga large number of developmental processes and diseases
(1–3) through fine tuning biological networks (4, 5). Expression
levels of miRNAs in oligodendroglia vary according to their dif-
ferentiation stages, indicating a possible role for miRNAs in reg-
ulating developmental processes among migratory, proliferating,
and myelinating oligodendrocytes (OLs) (6–9). Disruption of
miRNA biogenesis by Dicer ablation in oligodendroglia at post-
developmental stages results in a neurodegenerative phenotype
including demyelination, inflammation, and axon loss (10), sug-
gesting that miRNAs are also important for myelin maintenance
at later developmental stages. miR-23 is among the most abun-
dant miRNAs in OLs (6, 7). Previously, we reported that in the
presence of excess miR-23 in vitro, a greater proportion of cells
express mature markers of OLs that are paralleled by multipolar
morphological appearance with increased levels of mature myelin
proteins, indicating that miR-23 can enhance oligodendrogenesis
(11). In contrast, excessive lamin B1, a nuclear envelope protein
and target of miR-23, leads to lower numbers of cells expressing
mature markers with reduced levels of mature myelin proteins
both in vitro and in vivo, suggesting defective differentiation of
OLs. Importantly, the adverse effects of lamin B1 on OL cells can
be abrogated by overexpressing miR-23, which functions as a
negative regulator of lamin B1.
Here, we use mice in which miR-23a (one of the two miR-23
isoforms: miR-23a and b) overexpression is driven by an OL-
specific promoter [2′,3′-cyclic nucleotide 3′-phophodiesterase (Cnp)]
to investigate the effects of miR-23a on OL differentiation and
myelin synthesis in vivo. We demonstrated that in addition to the
previously identified target, lamin B1, miR-23a also directly
modulates the expression of two targets—phosphatase and tensin
homolog on chromosome 10 (PTEN) and a long noncoding RNA
(lncRNA), 2700046G09Rik (RIKEN cDNA 2700046G09 gene).
Through modulating expression of these molecules in myelinating
glia cells, miR-23a fine tunes activities of the serine-threonine
protein kinase Akt/mTOR (mechanistic target of rapamycin) and
mitogen-associated protein kinase (MAPK) pathways that promote
expression of myelin genes. Our results indicate that myelination
requires tightly regulated multilayer signaling pathways partly
converging downstream of PIP3 (phosphatidylinositol-3,4,5-tri-
sphosphate) with coordinated nuclear changes such as tran-
scription to trigger myelin gene expression, which then leads to
proper membrane wrapping of axons by OLs.
Results
Generation of Transgenic Mice Overexpressing miR-23a in
Oligodendrocytes. We have previously shown that miR-23 over-
expression enhances OL maturation in an established culture sys-
tem (11). In addition, miR-23a and miR-23b are both up-regulated
in OL under differentiation conditions compared with progenitor
status under proliferation conditions (Fig. S1A). Knockdown of
both miR-23a and miR-23b leads to significant reductions, whereas
knockdown of either miR-23a or miR-23b individually does not
cause obvious changes in expression levels of myelin genes (Fig.
S1B), suggesting that miR-23a and miR-23b can compensate for
each other in regulating OL maturation. Immunoreactivity of my-
elin basic protein (MBP) also demonstrated thatmiR-23a andmiR-
23b together had stronger effects on MBP expression than either
one alone (Fig. S1 C and D). Given that ectopic expression ofmiR-
23 can promote transcription of myelin genes in cultured glia and
purified OLs, we investigated the impact of overexpressingmiR-23a
on myelin formation in vivo. Northern blot analyses demonstrated
that miR-23a displays reduced expression in Dicer1-ablated neu-
rons, oligodendrocytes, and astrocytes (Fig. S2A), indicating ubiq-
uitous expression of miR-23a in the CNS. Murine Cnp promoter
was used to generatemiR-23a transgenic mice (Fig. S2 B and C), as
Cnp is highly expressed in developing OLs (12). Seven Cnp–miR-
23a founder lines demonstratedmiR-23a overexpression (Fig. S2D)
and three of these lines with different expression levels were
selected for further characterization. Quantitative RT-PCR
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(qRT-PCR) of oligodendrocyte progenitor cells (OPCs) pu-
rified from two lines display moderate-to-high levels of miR-
23a in proliferative medium and a further significant increase
in differentiation medium (Fig. S2E). Cnp–miR-23a mice
carrying one transgene allele were not overtly distinguishable
from control littermates but mice carrying two transgene
alleles developed a notable unilateral hindlimb paralysis as
early as postnatal day 5 (P5) (Fig. 1A). In addition, these Cnp–
miR-23a mice exhibited abnormal axial muscle tone (kypho-
sis), puffy eyes, and hindlimb ataxia from P42 (Fig. 1A).
Because there is no standard behavioral analysis specifically
designed for myelin assessment (13), we used several tests to
examine the Cnp–miR-23a mice for neurological dysfunction.
We examined general locomotor activity of mice at 20 wk of age.
Cnp–miR-23a transgenic mice showed motor impairment by re-
quiring more time to traverse the balance beam (5 mm and 11
mm) (Fig. 1B) and a higher rate of hindlimb slips and dragging
(Fig. S3 A and B). The hanging wire test was next used to ex-
amine whether the motor impairments were related to loss of
muscle power, and significant differences were observed (Fig.
1C). Additionally, Cnp–miR-23a mice required more time to
traverse the diagonal bar (Fig. 1D) and displayed a lower success
rate (Fig. 1E) as well as reduced duration on the coat hanger
(Fig. S3C), supporting that Cnp–miR-23a mice exhibited im-
paired motor function, which is likely a neurological conse-
quence of miR-23a overexpression in OLs.
miR-23a Regulates Oligodendrocyte Differentiation. To determine
whether overexpressing miR-23a affects OL differentiation in
vivo, oligodendroglia from transgenic mice under proliferation
or differentiation conditions were used to analyze the expression
levels of myelin genes. Interestingly, many of the myelin genes
[particularly late phase genes such as myelin-associated glyco-
protein (Mag), transferrin (Trf), and myelin oligodendrocyte
glycoprotein (Mog)] are simultaneously up-regulated in miR-23a
OLs compared with wild-type (WT) control cultures (Fig. 2A).
Early OL gene such as proteolipid protein (Plp) and Mbp were
also induced to a mild extent by miR-23a overexpression under
proliferation conditions (Fig. S3D). miR-23a overexpression not
only increased the number of OLs expressing MBP and MAG
(Fig. 2B and Fig. S3E), but also increased the overall expression
of PLP and MBP compared with control oligodendroglia (Fig.
2C), supportingmiR-23a as a key regulator of OL differentiation.
Overexpression of miR-23a Leads to Enhanced Myelination in the
Central Nervous System. Increased myelination in Cnp–miR-23a
mice compared with WT control was observed in the corpus
callosum stained with myelin-specific dye and CNP/MBP
antibodies (Fig. 3A). The size of the corpus callosum was in-
creased in Cnp–miR-23a mice at P90. Expression of myelin
proteins, such as CNP, MBP, and MAG was elevated (Fig. 3B).
Electron microscopy (EM) analysis revealed an increased num-
ber of axons exhibiting focal myelin pathology such as aberrant
myelin outfoldings caused by hypermyelination at P180 (Fig. 3 C
and D, yellow and green arrowheads) or “invaginating” recurrent
loops (Fig. 3D, red arrowhead), which showed similar features
with the myelin sheath from which they had originated. We
quantified the myelin abnormalities by comparing electron mi-
croscopy of rostral corpus callosum from Cnp–miR23a and
controls at 6 mo of age. G ratios for the transgenic (TG)+/WT−
or TG+/TG+ Cnp–miR-23amice are 0.6144 (±0.0043) and 0.6366
(±0.0045), respectively, which are significantly different from
controls (0.7088 ± 0.0038) (Fig. 3E, Upper Right, P < 0.01). In-
creased myelin thickness was evident for axons of small calibers
(Fig. 3E, Upper Left), but not all fibers were visibly hyper-
myelinated. The overall size distribution of callosal axons was
similar in transgenic and control mice (Fig. 3E, Lower). EM
demonstrated increased layers of myelin sheath wrapping in ei-
ther small or large caliber axons with increased membrane wraps
(Fig. 3F). Together, these data implicate miR-23a in the regula-
tion of myelin thickness and proper myelin folding in the central
nervous system (CNS).
Unbiased Search for miR-23a Targeted Molecules and Mechanisms.
To further investigate the mechanisms of miR-23a in OL de-
velopment and myelination, we set out to identify other relevant
targets that are regulated by miR-23a. A total of 1,179 genes
were identified to demonstrate differential expression between
Cnp–miR-23a and WT mice [absolute fold change (FC) >1.5,
multitest adjusted P value ≤0.05 correspondent to unadjusted
P value ≤0.013 by cufflink] (Fig. 4A and Datasets S1 and S2).
This included many known myelin-formation–associated genes,
which were highly expressed in Cnp–miR-23a (Fig. 4B). Addi-
tionally, we found that genes specific to early stages of oligo-
dendroglia development, such as Pdgfra and Lmnb1, displayed
reduced levels in OLs purified from Cnp–miR-23a.
Next, we compared the differentially expressed genes with the
reference lists of genes that are enriched in astrocytes, neurons,
and OLs (14). The OL-enriched genes are mostly up-regulated in
Cnp–miR-23a, whereas the neuron-enriched genes tend to be
down-regulated (Fig. S4 C and D). Upon further dissection of
miR-23a on promoting OL differentiation, we found that genes
enriched in more mature OLs, including OLs and the most
mature MOG+ OLs (14), are mostly up-regulated (Fig. 4C and
Fig. S4E). Collectively, the results of RNA sequencing (RNA-
Seq) suggest a role for miR-23a in promoting the progression
of less-differentiated OPCs into myelinating and mature OLs, likely
by promoting the expression of mature OL-enriched genes. This
Fig. 1. Cnp–miR-23a mice exhibited impaired motor function. (A) Mor-
phological abnormalities displayed in Cnp–miR-23a mice: hindlimb paralysis
(Upper Left ), loss of foot extensor tone (Lower Left), kyphosis (Upper Right )
and puffy eyes (Lower Right). Mice at the age of P150 were analyzed with
balanced beam test (B), horizontal wire hanging test (C), and coat hanger
test (D and E). Measurement of time for Cnp–miR-23a mice to traverse
balance beams (B) and to hang in horizontal wire (C) and measurement of
latency to reach the diagonal bar (D) and successful rate to reach diagonal
bar (E) are shown. Data are presented as means ± SEM, n = 7 per genotype,
*P < 0.05, unpaired Student t test. Filled bars represent Cnp–miR-23a and
open bars denote WT mice.
Fig. 2. Overexpressing miR-23a promotes OPC differentiation. (A) Expres-
sion of OL markers in cells purified from P7 Cnp–miR-23a mice was assessed
using qRT-PCR. Data are presented as means ± SEM, *P < 0.05, **P < 0.01,
unpaired Student t test. n = 4 per genotype. Filled bars represent Cnp–miR-
23a OLs and open bars denote WT OLs. (B) Quantification of MBP- or MAG-
positive cells in OPCs purified from P7 WT and Cnp–miR-23a mice cultured
for 4 d in vitro (DIV) in differentiation medium. The total numbers of cells
were determined by DAPI staining. Data are presented as ratio ± SEM from
three independent experiments. *P < 0.05. (C) Representative Western
analyses showed increased expression of PLP and MBP in Cnp–miR-23a OLs
relative to control. Protein lysates were purified from OPCs cultured at 4 DIV
in differentiation media. GAPDH was used as a loading control.
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regulation may be accompanied by repression of neuron-enriched
and (to a lesser extent) astrocyte-enriched genes.
miR-23a Target Molecules: PTEN and 2700046G09Rik. In silico pre-
diction (miRANDA and TargetScan) followed by luciferase re-
porter assay was carried out to identify potential direct targets of
miR-23a for regulating CNS myelination. We reasoned that true
miR-23a–targeted genes would display positive correlation
between RNA-Seq and luciferase reporter analysis. Among 35
candidates examined in this study, PTEN and 2700046G09Rik
(Fig. S5A) displayed positive correlation. In addition, their genomic
locations are rather close, which raised a possibility for the lncRNA
(2700046G09Rik) to exert cis-regulatory effect on the neighboring
PTEN gene (15). Therefore, we investigated them further. The
repression of PTEN and enhancement of 2700046G09Rik by miR-
23a were validated by mutagenizing their respective miR-23a
binding elements (Fig. S5 B–D) miR-23 exhibits a gradually in-
creased expression pattern during postnatal development (11), and
the true direct target genes of miR-23a should display expression
patterns correlating with miR-23a expression. Indeed, the protein
levels of PTEN display a gradual decrease from postnatal day 1 to
10 months of age (Fig. 5A), whereas the levels of 2700046G09Rik
display a gradual increase beginning at postnatal day 60 (Fig. 5B).
We next validated the interaction of miR-23a and PTEN or
2700046G09Rik by UV–cross-link RNA immunoprecipitation
(RIP) (16). FLAG-AGO2 immunoprecipitation was conducted in
Fig. 3. Enhanced myelination in Cnp–miR-23amice. (A) Corpus
callosum in WT and Cnp–miR-23a mice at P90 showing en-
hanced myelination by Luxol Fast blue and CNP/MBP immu-
noreactivities. (B) Quantification of MBP, CNP, and MAG in
corpus callosum by Western blot analysis (n = 3, *P < 0.05,
unpaired Student t test). (C and D) Myelin abnormalities in
corpus callosum of Cnp–miR-23a mice at P180, including
hypermyelination (green arrowheads), myelin debris (red
arrows), aberrant outfoldings (yellow arrowheads), and in-
vaginating recurrent loops in axons (red arrowhead). [Scale bar
for C, 1 μm (Left) or 2 μm (Right)]. (E) Quantitation of myelin
thickness by modified G-ratio analysis and axon size distribu-
tion for the corpus callosum (age, P180; n = 2 per genotype;
control, WT littermates; TG+/WT, one allele of transgene;
TG+/TG+, two alleles of transgene). (Upper Left) Scatter plots
comparing G ratios from TG+/WT (gray), TG+/TG+ (red), and age-
matched controls (black) in relation to myelin sheath inner di-
ameter. (Upper Right) Myelin thickness is significantly increased
in Cnp–miR-23a mice. (Lower) Axonal calibers are comparable
between Cnp–miR-23a mice and controls. (**P < 0.01, one-way
ANOVA). (F) Hypermyelination in Cnp–miR-23a mice (Right) is
caused by additional membrane wraps, as visualized by ultra-
structure and periodicity of myelin sheaths. [Scale bar, 500 nm
(Upper) and 100 nm (Lower)].
Fig. 4. Differentially expressed transcriptome in
miR-23a–overexpressing oligodendroglia. (A) Hier-
archical clustering and analysis of overall expressed
genes in cultured OLs overexpressing miR-23a. (B)
Differential expression of known myelin-associated
genes plotted on a color scale (green, low expres-
sion; red, high expression). (C) Volcano plot and
kernel density estimation demonstrate the differ-
ences in the expression patterns of genes known to
be enriched at different stages of oligodendrocyte
differentiation (OPC, progenitors; OL, myelinating
OL; MOG+, mature OL expressing MOG) in response
to miR-23a overexpression.
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HEK293 cells transiently coexpressingmiR-23a and its targets. By
RIP-qPCR, PTEN or 2700046G09Rik coprecipitating with AGO2
was specifically enriched in miR-23a–transfected cells (Fig. 5C),
indicating that miR-23a is facilitating AGO2 association with
PTEN or 2700046G09Rik. Furthermore, using a biotin-coupled
miR-23a mimic, we observed a significant enrichment of PTEN or
2700046G09Rik in miR-23a–captured fraction compared with
control (Fig. 5D). Consistently, the levels of PTEN are decreased
(Fig. 5E), whereas 2700046G09Rik are increased (Fig. 5F) in
spinal cord and cerebellum of Cnp–miR-23 mice compared with
WT mice. Taken together, these results strongly imply that direct
interactions exist between miR-23a and PTEN or 2700046G09Rik
and that PTEN and 2700046G09Rik are true miR-23a targets.
2700046G09Rik Participates in Myelin Regulation. To understand the
role of 2700046G09Rik in oligodendroglial differentiation and
myelin production, we examined its expression in various cells.
RNA levels of 2700046G09Rik were significantly higher in cul-
tured OLs fromWTmice under differentiation conditions, whereas
astrocytes displayed a comparable level to cultured OPCs under
proliferative conditions (Fig. S6A). Congruently, its level is in-
creased in OLs from Cnp–miR-23a compared with WT OLs.
Overexpression of 2700046G09Rik in cultured OLs led to moder-
ately increased expression of MAG protein (Fig. S6B). In addition,
promoter region reporter assays revealed that two important oli-
godendrocyte-associated transcription factors for OPCs differenti-
ation to OLs, YY1 and Nkx2.2 (17, 18), display positive effects on
the expression of 2700046G09Rik (Fig. 5G). Together, these data
support a potential unique role for 2700046G09Rik in the regula-
tion of myelination.
Interplays Among miR-23a, 2700046G09Rik, and PTEN. The compet-
itive endogenous RNA hypothesis (19) suggested that coding
and noncoding transcripts share common miRNA binding ele-
ments and lead to altered transcriptome homeostasis. To test
whether PTEN, 2700046G09Rik, and miR-23a have interplay in
regulating OL and myelin, we first investigated the possible
regulatory effects of 2700046G09Rik on PTEN in cell culture.
The coding region plus 2 kb 3′-UTR of PTEN was cotransfected
into HEK293 with eithermiR-23a or 2700046G09Rik and Western
blot analysis revealed thatmiR-23a and 2700046G09Rik both exert
repressive effects on PTEN (Fig. 6A). Next, luciferase reporters
carrying full-length (6 kb) 3′-UTR (20) of PTEN was coexpressed
with miR-23a and/or 2700046G09Rik (Fig. 6B). 2700046G09Rik
did not significantly alter the level of PTEN, whereas miR-23a
displayed moderate repression. Interestingly, the level of PTEN
was reduced by 2700046G09Rik only in the presence of the PTEN
coding region together with 2 kb 3′-UTR (Fig. 6 A and C). This
effect was abrogated by mutating the miR-23a binding motif of
2700046G09Rik (Fig. 6C, lane 4), suggesting that an intact miR-
23a binding motif is necessary for the full repressive effect of
2700046G09Rik on PTEN and that there is a possible interplay
between miR-23a and 2700046G09Rik for regulation of PTEN. As
expected, the level of PTEN was further reduced by the presence
of both miR-23a and 2700046G09Rik (Fig. 6C, lane 5).
We next investigated the possible effect of 2700046G09Rik and
miR-23a on each other. Inhibition of de novo transcription by ac-
tinomycin D treatment in HEK293 cells showed miR-23a has a
longer half-life compared with U6 small nuclear RNA (snRNA)
(Fig. 6D). Cotransfection of 2700046G09Rik containing perfect
miR-23a binding elements with miR-23a led to higher ex-
pression of miR-23a in HEK293 cells following 24-h treatment of
actinomycin D, whereas miR-23a did not alter stability of
2700046G09Rik regardless of the presence of miR-23a binding
elements (Fig. 6E). These results suggested that 2700046G09Rik
enhances miR-23a stability. HEK293 cells expressing miR-23a,
2700046G09Rik, or both were then accessed by RIP-qPCR fol-
lowing immunoprecipitation of DCP1 (decapping enzyme 1)
for P body (processing bodies). Coexpression of miR-23a and
2700046G09Rik significantly increased miR-23a in DCP1
immunoprecipitant (Fig. 6F), indicating enrichment of miR-
23a in P bodies by 2700046G09Rik. Altered stability and cellular
localization of miR-23a by 2700046G09Rik suggest a unique role
for noncoding transcripts in the regulation of PTEN transcript.
Together, these results demonstrate a network of regulatory
pathway, including miR-23a, 2700046G09Rik, and PTEN in the
regulation of OL development and myelin gene expression.
Signaling Pathways Modulated by miR-23a Overexpression. Because
PTEN is a lipid phosphatase that negatively regulates the
phosphatidylinositol 3-kinase (PI3K) signaling pathway (21), and
accumulating evidence indicates that the PI3K/Akt/mTOR
pathway regulates CNS myelination (22, 23), we investigated the
possibility that miR-23a has a role in modulating the PI3K/Akt/
mTOR signal transduction cascade. Western blot analysis re-
vealed that the level of phosphorylated Akt was higher in miR-
23a brain homogenate (Fig. 7A), indicating activation of Akt
signaling. In addition, levels of PI3K signaling and MAPK ac-
tivity, but not protein kinase A (PKA), were also elevated (Fig. S7
A–C). Ectopic expression of PTEN in cultured OLs purified from
control and Cnp–miR-23a mice at P7 reduced expression levels of
Fig. 5. miR-23a regulates PTEN and 2700046G09Rik. (A) Western analysis of
PTEN, MAG, MBP, and GAPDH from C57BL/6 brain at indicated ages. (B) qRT-
PCR of 2700046G09Rik from C57BL/6 brain. **P < 0.01 compared with P0,
one-way ANOVA. (C) Immunoprecipitation of FLAG-tagged AGO2 from
HEK293 transfected with PTEN 3′-UTR or 2700046G09Rik and FLAG-AGO2
plus vector or miR-23a. PTEN and 2700046G09Rik levels were quantified by
qRT-PCR, and the relative immunoprecipitate (IP)/input ratios were plotted.
n = 4, ***P < 0.001, unpaired Student t test. (D) The 3′-end biotinylatedmiR-
23a duplexes were transfected into HEK293. After streptavidin capture, in-
put and bound fractions were evaluated by qRT-PCR. n = 4, *P < 0.05. (E)
Western analysis of PTEN in spinal cord or cerebellum from WT and Cnp–
miR-23a mouse brain at P90. (F) qRT-PCR of 2700046G09Rik transcript using
spinal cord or cerebellum from control and Cnp–miR-23a mice. n = 3, *P <
0.05. Filled bars represent Cnp–miR-23a and open bars denote WT mice. (G)
Luciferase activity of firefly reporter gene fused with the 3-kb 2700046G09Rik
promoter in the presence of indicated transcription factors. n = 4, **P < 0.01
compared with control, one-way ANOVA. All data are presented as ratio of
means ± SEM.
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MAG compared with vector control (Fig. 7B). Overexpressing
dominant-negative Akt (AKT-DN) dramatically reduced expression
of myelin proteins in Cnp–miR-23a (Fig. 7C), consistent with the
hypothesis that Akt acts downstream of miR-23a to mediate myelin
formation. Rapamycin, the mTOR inhibitor, treatment reduced
expression levels of several myelin proteins (PLP, MOG, and
MAG) in cultured OLs isolated from Cnp–miR-23amice (Fig. 7D).
Collectively, these results confirm that PTEN/PI3K/Akt/mTOR is
part of the cascade in miR-23a–mediated regulation and that
mTOR acts downstream of miR-23a to mediate myelin production.
Discussion
The deposition of a precise amount of myelin around axons is
necessary for proper impulse transmission, whereas too much or
too little myelin surrounding axons causes nerve dysfunction in
various neurological diseases. We have generated a mouse model
overexpressing miR-23a that produces excessive myelin protein
and myelin formation in the CNS. These mice display severe
motor deficits beginning in postnatal life. Because Cnp expresses
in both central and peripheral nervous systems (PNS), we cannot
exclude the possibility that the motor deficits observed in Cnp–
miR-23a mice were caused, at least in part, by peripheral myelin
abnormality. Using this mouse model, we also produced a profile
for differentially expressed genes that are associated with miR-23a
overexpression. This miR23a-myelin transcriptome offers a use-
ful resource for future investigation in understanding the sig-
naling networks and factors that are required for the regulation of
OL development/myelination and other miR-23a–regulated
biological functions.
Our demonstration of miR-23a overexpression in OLs result-
ing in hypermyelination of mouse brain establishes a regulatory
role for miR-23a in myelin production. Overexpression of miR-
23a leads to up-regulation of genes in OL clusters, but sub-
stantial down-regulation of genes in neuronal clusters. This
suggests that miR-23a not only functions to enhance OL lineage
progression and promote myelin proteins but also safeguards
against expression of genes for other cell lineages that might in-
terfere with the progression of OL maturation and myelin sheath
formation. This is consistent with previous reports that miRNAs
function as guardians to enhance lineage-related protein identity
and to repress other nonlineage protein expression (6, 9).
Elevated PIP3 signaling or loss of PTEN in myelinating glia has
been shown to cause hypermyelination in the CNS (21, 24) and
PNS (25). PTEN antagonizes PI3K signaling and negatively reg-
ulates the ERK1/2-MAPK pathway (26). Akt and mTOR,
downstream effectors of PI3K signaling, promotes OL differ-
entiation and myelin generation (22, 27, 28). Transgenic mice
overexpressing constitutively active Akt kinase in OLs enhance
myelin formation in the CNS but not PNS (22), and this is
mediated through downstream mTOR signaling (23). The
present study revealed that elevated level of miR-23a in OLs is
sufficient to promote formation of myelin that can last until
older age (at least 1-y old) partly through the Akt/mTOR and
MAPK signaling pathways by targeting PTEN. A recent study
reported that the cAMP-response element-binding protein
(CREB) promotes glioma formation by up-regulating miR-23a,
leading to down-regulation of its direct target, PTEN (29). Thus
far, we have not observed obviously increased incidence of gli-
oma formation in murine brains overexpressing miR-23a in
myelinating glia.
Duplications of LMNB1 (which encodes lamin B1) have been
identified to cause adult-onset autosomal dominant leukodystrophy
(30). Excessive lamin B1 expression reduces occupancy of Yin
Yang 1 (YY1) transcription factor on the promoter region of PLP,
thus leading to down-regulation of PLP abundance, conferring
myelin loss in the mouse brain (31). Reduced levels of both PTEN
and LMNB1 by miR-23a are likely to participate in hyper-
myelination observed in the present study.
To date, long noncoding RNAs have been shown to function as
regulators of gene expression transcriptionally and posttranscrip-
tionally through working at the DNA level (32), modulation of
chromatin modifications, or transcriptional interference by anti-
sense transcription (1). miRNAs bind to the coding sequences or
3′-UTRs of target transcripts, thus leading to impaired translation
or increased degradation of transcripts (33). Interestingly,
Fig. 6. miR-23a and 2700046G09Rik repress PTEN. (A) Representative
Western analysis of PTEN from HEK293 coexpressing PTEN coding sequences
fused to 2-kb PTEN 3′-UTR with either miR-23a, 2700046G09Rik, or both. (B)
Luciferase activity of firefly reporter gene fused with the 6-kb full-length
PTEN 3′-UTR (without coding region) in the presence of indicated RNA. WT,
2700046G09Rik with normal miR-23a binding elements. Mut, 2700046G09Rik
with mutated miR-23a binding elements (M123, Fig. S5). Data presented as
ratio of means ± SEM *P < 0.05 compared with control; †P < 0.05 compared
with WT 2700046G09Rik; one-way ANOVA. (C) Representative Western
analysis of PTEN from HEK293 coexpressing PTEN coding sequences fused to
2-kb 3′-UTR (containing WT miR-23a binding elements) together with miR-
23a and/or 2700046G09Rik. (D) qRT-PCR analysis of miR-23a in HEK293
transfected with miR-23a plus vector (gray), 2700046G09Rik carrying WT
(black), or Mut (blue) miR-23a binding elements followed by actinomycin D
treatment. n = 6, *P < 0.05 compared with vector control. One-way ANOVA
analysis with Newman–Keuls test at 24 h. (E ) qRT-PCR analysis of
2700046G09Rik transcript in HEK293 transfected with miR-23a plus
2700046G09Rik carrying WT (black) or Mut (blue) miR-23a binding ele-
ments followed by actinomycin D treatment. n = 6, NS, nonsignificant. (F)
Immunoprecipitation of DCP1 from HEK293 cells transfected with vector,
miR-23a, 2700046G09Rik, or miR-23a plus 2700046G09Rik. miR-23a levels
were quantified by qRT-PCR, and the relative immunoprecipitate (IP)/input
ratios were plotted. n = 4, NS, nonsignificant, *P < 0.05, †P < 0.05.
Fig. 7. miR-23a overexpression leads to activation of the Akt/mTOR path-
way. (A) Western analysis of phosphor-AKT (S473) expression in corpus cal-
losum of P90 WT or Cnp–miR-23a mice. (B–D) Representative Western
analyses of myelin proteins in mouse OPCs from WT or Cnp–miR-23a mice
cultured for 4 DIV in differentiation media. Purified OPCs were over-
expressing PTEN (B) or dominant-negative AKT1 (AKT-DN) (C). (D) Purified
OPCs were treated with 15 nM rapamycin.
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2700046G09Rik, one of the miR-23a targets identified in this
study, is a lncRNA in cis with the neighboring PTEN gene.
miR-23a up-regulates the 2700046G09Rik transcription, and
2700046G09Rik in turn lengthens the half-life of miR-23a, thus
potentiating its repressive effects. 2700046G09Rik also can
lead to a reduced level of PTEN expression. This down-regu-
lation is independent of miR-23a–responsive elements (MREs)
on PTEN, but requires the miR-23a MREs on 2700046G09Rik.
Therefore, repressive effects on PTEN can either occur with
miR-23a alone or in coordination with 2700046G09Rik. It is
possible that 2700046G09Rik targets the PTEN with the assis-
tance of miR-23a. In addition, 2700046G09Rik may aid in the
cellular recompartmentation of miR-23a into P bodies, which
could also contribute to the regulation of PTEN level. Interplay
of miR-23a and 2700046G09Rik in this study infers additional
molecular processes in regulating mRNA decay (Fig. S8).
lncRNAs are tightly controlled by environmental cues and in-
ducible functions (34). Intriguingly, we discovered that pro-
moter of 2700046G09Rik can be activated by two important
transcription factors (YY1 and Nkx2.2) (17, 18, 35) in OL
development. Our results are consistent with a previous report
that dynamic changes of lncRNA transcriptome are important
for glia differentiation (36). We propose that the presence of
2700046G09Rik in oligodendroglia potentiates and signals the
activation of the miR-23a/PTEN/Akt/mTOR and MAPK cas-
cades in the correct developmental stage, thus regulating the
expression of myelin genes in OLs.
Noncoding RNAs (ncRNAs) have emerged as a major com-
ponent in epigenetic regulation, specifically in orchestrating neural
gene expression and function and gene–environment interactions
(2, 37). Elevated levels of miR-23a are identified in severe
demyelinated regions of brains derived from the murine model
of autosomal dominant adult-onset leukodystrophy (Fig. S9) and
active multiple sclerosis lesions in human brains (38, 39).
Interestingly, increased frequency of miR-23a rs(refSNP) 3745453
C allele has been identified as a potential risk factor of multiple
sclerosis (39). Therefore, miR-23a may participate in not only
modulating genes in normal myelin regulation but also in myelin
repair. Through identification ofmiR-23a targets, we revealed that
miR-23a and some lncRNAs (2700046G09Rik) interact in a com-
plex regulatory network to modulate genes that are important for
myelin formation/maintenance. Understanding the layers of com-
plexity in the molecular mechanisms that underlie the elaboration
of myelin synthesis and maintenance has undergone intensive in-
vestigation and recent advances have uncovered unique insights
into these processes. Identifying targets of miR-23a and de-
veloping future demyelinating experiments using this murine
model will provide the opportunity to better understand RNA
regulatory networks and offer future therapeutic approaches
against demyelinating diseases.
Materials and Methods
Details for generation of Cnp–miR-23a mice oligodendrocyte culture, RNA-
Seq analysis, immunoblotting, immunostaining, and qRT-PCR are provided
in SI Materials and Methods. Cnp-miR-23a mice were generated and
maintained in C57BL/6 background. All animal experiments were per-
formed under approval by the Animal Care and Use Committee at the
University of California, San Francisco.
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SI Materials and Methods
Generation of Cnp–miR-23a Mice. We generated transgenic mice
overexpressing microRNA-23a (miR-23a) driven by the Cnp
promoter (1). To selectively overexpress miR-23a among the
miR-23a–miR-27a–miR-24–2 cluster, various miR-23a flanking
sequences were expressed in HEK293 cells. Northern blotting
revealed that the strongest expression of miR-23a transgene
occurred when the pre–miR-23a was flanked on each side with
120-nt genomic sequences (Fig. S2B). The 120-nt flanking se-
quences only included partial pre–miR-27a; therefore, it did not
result in overexpression of miR-27a and miR-24–2. This mouse
genomic fragment was further subcloned into an expression
vector downstream of a murine Cnp promoter for generating
transgenic animal (Fig. S2C). The pre–miR-23a plus 120-bp
flanking sequences on each side was inserted downstream of Cnp1
and Cnp2 promoters and the construct was used to generate
transgenic C57BL/6 mice at the University of California, San
Francisco (UCSF) mouse transgenic core. Positive founders were
identified by PCR amplification of tail DNA using Cnp F (5′-
GCCCCAGGCCTCCAAACAGGACAT) and miR-23a R (5′-
GACCTTGCTCACAAGCAGCTAAG). miR-23a expressed
in oligodendrocytes in the CNS was noted in all seven lines. For
simplicity and consistency, Cnp–miR-23a-H was used for follow-
up analyses. A notable unilateral hindlimb paralysis in Cnp–miR-
23a mice was found in ∼25% of transgenic mice derived from
intercrossing middle and high expressing lines of Cnp–miR-23a.
All mouse experiments were performed in compliance with
animal protocols approved by the Animal Care and Use Com-
mittee at UCSF.
Behavioral Examination. All behavioral evaluations were per-
formed in the morning between the hours of 9:00 AM and noon.
Balance beam. Motor coordination, balance, and hindlimb place-
ment were evaluated by assessing the ability of mice to transverse
two types of balance beams to reach an enclosed safety platform.
Each mouse was tested for its ability to transverse different styles
of 41-cm-long scored Plexiglas beams (2). Two square (5 mm and
11 mm) beams were used in this study. Beams were placed hor-
izontally 50 cm above a table. A brightly illuminated start plat-
form and a darkened enclosed 80,000 cm3 escape box (20 × 20 ×
20 cm) were situated at the end of the beam. Time to traverse
each beam was recorded for each trail with a 20-s maximum
cutoff, and falls were scored at 20 s. The number of foot slips and
whether a mouse dragged itself across the beam on its abdomen
was also recorded.
Horizontal wire hang test. A standard wire cage lid is used with
masking tape placed around the perimeter of the lid to prevent
animals from escaping. After an animal is placed in the lid, the lid
is shaken gently to induce a firm grip, and the lid is inverted. The
lid is held horizontally 20 cm above the cage litter. Latency to fall
is recorded for up to 2 min (3).
Coat hanger test.Mice are placed in the middle of a thin horizontal
bar (2 mm diameter; 40 cm length; 85 cm higher from a blanket-
covered table), in an upside-down position. The time taken for the
mice to travel along the bar of the triangular-shaped coat hanger
was recorded together with the latencies to fall with a cutoff point
of 2 min.
Histology and Immunostaining.Mice were anesthetized with avertin
and perfused through the left ventricle with PBS followed by 4%
(wt/vol) paraformaldehyde in PBS. Brains and spinal cords were
postfixed overnight at 4°and cryostated. Coronal section (15 μm)
were incubated overnight at 4° in primary antibody followed by
1 h at room temperature with the corresponding fluorescently
labeled secondary antibodies conjugated to either Alexafluor
495 or Alexafluor 594 (1:500; Invitrogen) and analyzed as de-
scribed previously (4). Myelinated fibers were visualized by
Luxol Fast Blue (Sigma) staining.
Cell Culture, Transfection, and Immunocytochemistry. HEK293 cells
were cultured as described previously (4). Primary glial cultures
were isolated from adult Cnp–miR-23a overexpressing transgenic
mice or WT littermates using standard methods (5). Plasmid or
single-stranded RNA transfections (Dharmacon) were performed
by using FuGene HD (Roche) or nucleofector electroporation
with the Amaxa system (Amaxa Biosystems). Cells grown on cov-
erslips were fixed in methanol at −20 °C or 4% (wt/vol) para-
formaldehyde in PBS at room temperature. Immunocytochemistry
was performed as described previously (4).
Luciferase Reporter Assay. Luciferase activities in the cell extracts
were assayed 48 h after transfection as described previously (4).
pGL3-promoter expression constructs were cotransfected to
normalize for transfection efficiency. pSV-RL-Luc (Promega)
was used to place 3′-UTR downstream of a Renilla luciferase
in this study.
Transmission Electron Microscopy and G-Ratio Analysis. Six-month-
old animals were deeply anesthetized and intracardially perfused
with 1% paraformaldehyde, 2% (vol/vol) glutaraldehyde in 0.1
M sodium cacodylate buffer, pH 7.4 (n = 2 per group for TG+/WT,
TG+/TG+ Cnp–miR-23a, and wild-type mice). Brains were
postfixed in 2% (wt/vol) osmium tetroxide in the same buffer, en
block stained in 2% (wt/vol) aqueous uranyl acetate, dehydrated,
infiltrated, and embedded in LX-112 resin (Ladd Research In-
dustries). Semithin sections of corpus callosum were stained with
toluidine blue for tissue identification. Methods were performed
as previously described with the above modifications (6). Images
were collected using the Tecnai electron microscope at the UCSF
EM facility.
G ratio of axons in the area of interest was obtained as a ratio of
the diameter of an axon over the diameter of the axon plus as-
sociated myelin sheath. Approximately 150–200 axons per animal
for each group of two animals were used. Digitized and cali-
brated images were analyzed using ImageJ (National Institutes
of Health).
RNA Extraction, Quantitative RT-PCR, and UV–Cross-Link RIP. Total
RNA from WT and Cnp–miR-23a brain tissues were isolated
using the RNeasy Mini kit according to the manufacturer’s in-
structions (Qiagen). For RNA-sequencing (RNA-Seq) analysis,
we isolated OLs from Cnp–miR-23a and WT mice at P7 using
established immunopanning methods (5), and three independent
preparations of OLs were pooled for RNA-Seq analysis. Total
RNA was collected from purified mouse OPCs cultured for 4 d
in vitro (DIV) in +PDGF −T3 media followed by 4 DIV in
−PDGF +T3 media. Total RNA samples (10 μg, size >200 nt)
isolated using the Qiagen RNeasy Mini kit were pooled from
three independent preparations. RNA purity was assessed using
the ND-1000 Nanodrop Spectrophotometer (NanoDrop). Each
RNA sample had an A260:A280 ratio above 1.8 and A260:A230
ratio above 2.0. cDNA was generated from total RNA (2 μg) by
SuperScript III first-strand synthesis system (Invitrogen) and
transcripts were detected and amplified by quantitative real-time
PCR in a RotorGene RG3000 real-time PCR system (Corbett
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Research) with the FastStart SYBR-green-containing master
(Rox) PCR kit (Roche). UV–cross-link RIP was performed as
described (7).
RNA-Seq Analysis.RNA-Seq was carried out at Active Motif (www.
activemotif.com). The sequencing results were paired-end 36-bp
reads shipped in FASTQ format. We used an analysis pipeline
composed of commonly used software, including Bowtie (8),
TopHat (9), Samtools (10), and Cufflinks (11) to align and as-
semble the short reads. We used a “reference based” approach,
in which the alignment and assembly were based on the refer-
ence mouse genome sequence (assembly mm9 from UCSC) and
the ENSEMBL annotation of mouse genes (NCBIM37.61). Briefly,
we first used samstats (samstats.sourceforge.net) to examine the
quality of the RNA-Seq reads. The reads were then aligned to the
mouse genome using the splice-aware aligner TopHat, which
used Bowtie for short read alignments. The aligned reads were
sorted and indexed using Samtools. We then used Cufflinks to
assemble the reads into transcripts, which converted the read
coverage into the fragments per kilobases of transcripts per
million fragments mapped (FPKM) metric of expression. The
Cufflinks also came with Cuffcompare and Cuffdiff for unifying
the names of the assembled transcripts and the expression levels
among different RNA-Seq samples were compared.
Absolute difference, fold change plot, and kernel density estimation. The
fold changes (FCs) (log2 of the FCs in FPKM) between wild-type
(control) and Cnp–miR-23a and absolute differences (AD) (log10
of the absolute differences in FPKM) values were calculated for
each gene based on the RNA-Seq results. Data points of genes in
a defined gene set such as the genes overexpressed in neurons
are plotted with FC as the x axis and AD as the y axis. Distri-
bution of the genes in the plot indicated whether the genes were
significantly up-regulated (toward the upper-right corner) or
down-regulated (toward the upper-left corner). Distribution
density of the data was estimated using the kernel density esti-
mation method from R (www.R-project.org). Based on the es-
timated density and a cutoff value of 95%, control lines were
drawn that encircle the colored areas in plots. These colored
areas allow us to visualize the distribution of the data points. By
the definition of density, with greater than 95% chances, any
data point from the correspondent gene set should fall inside the
colored area. The density plots of different gene sets, such as the
genes are clustered in neurons, oligodendrocytes, astrocytes or
oligodendrocytes at different developmental stages, are super-
imposed together to visualize the differences among these gene
sets in the wake of aberrant expression of miR-23a.
MicroRNA target prediction. MicroRNA (miRNA) targets were pre-
dicted from two sources. First, we retrieved 3′-UTR of all mouse
genes from ENSEMBL via BioMart and predicted the targets
using Miranda (www.microrna.org/microrna/home.do) (12). We
scanned for the targets that have strict seed pairing. Besides that, the
default parameters of Miranda were used. The same analysis was
also carried out for mouse long noncoding RNAs (lncRNAs) an-
notated in ENSEMBL, where the targets were predicted along the
whole sequence of the lncRNAs. We used the target prediction
fromTargetScan (www.targetscan.org/mmu_50/) (13) as the second
source. We retrieved the aligned 3′-UTR sequence from TargetS-
can and kept only the sequences fromhuman, chimpanzee, dog, and
mouse. The targets were then scanned using the targetscan_50.pl
script fromTargetScan. The resulting sets of targets were conserved
in the four mammal species. The target information was mapped
back to the transcripts and formed a combined set of data with both
expression and target information.
Comparing with other transcriptome data. We compared our RNA-
Seq result with the available transcriptome data for astrocytes,
neurons, and oligodendrocytes (14). We retrieved the cell-type–
enriched genes and mapped them to our RNA-Seq data and
then plotted the absolute differences versus the FCs between
gene expression in oligodendrocytes from Cnp–miR-23a trans-
genic mice and control mice.
Multidimensional scaling analysis. Multidimensional scaling (MDS)
(15) is carried out to visualize the dissimilarities in expression
changes among genes of neuron, astrocyte, or oligodendrocyte
categories. Genes from these categories are pooled together and
differentially colored. The log2 of FCs in expression between
Cnp–miR-23a and control is calculated for each gene and the
Manhattan distances in log2 of FC are calculated for all gene
pairs. Two-dimension MDS is carried out on the distance matrix
using the classical (metric) MDS method from the R pro-
gramming language. The axes of the plot are converted coor-
dinates from the distances that are optimized in the MDS
process to recapitulate the distances among thousand of genes in
a 2D space. From the plot, there is obvious clustering of genes in
different categories, suggesting that genes in different categories
are differently influenced by aberrant miR-23a expression.
Statistical Analysis.Data were presented as mean ± SEM and data
comparison was undertaken using the two-tailed independent
Student t test or two-way ANOVA followed by one-way ANOVA
with Newman–Keuls post hoc test (Prism5; GraphPad). The
significant difference was set at P < 0.05, unless otherwise stated.
For differential expression analysis of RNA-seq data, the sig-
nificant difference was set at P ≤ 0.013 at a Benjamini–Hochberg
(16) adjusted false discovery rate less than 0.05 by pairwise
sample comparison using Cuffdiff and FC cutoff was set at 1.5.
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Fig. S1. miR-23a tightly regulates differentiation status of OLs. (A) Quantitative RT-PCR (qRT-PCR) ofmiR-23a andmiR-23b in OPCs isolated from C57BL/6 mice
under proliferative (OPC, open bars) or differentiation (OL, filled bars) conditions. Data are presented as ratio of means ± SEM, n = 4, *P < 0.05, **P < 0.01,
unpaired Student t test. (B) Expression levels of myelin genes in cultured OPCs containing antagomirs knocking downmiR-23a,miR-23b, ormiR-23a+miR-23b in
differentiation conditions for 4 d. Data are presented as ratio of means ± SEM, n = 3, *P < 0.05, one-way ANOVA with Newman–Keuls post hoc test. (C)
Representative images of OPCs transfected with FITC-labeled antagomirs against miR-23a, miR-23b, or miR-23a+miR-23b and differentiated for 4 d before
stained with MBP. [Scale bar, 50 μm (Top) or 10 μm (Middle and Bottom)]. (D) Quantification of MBP immunoreactivity in OPCs transfected with FITC-labeled
antagomirs against miR-23a, miR-23b, or miR-23a+miR-23b and differentiated for 4 d. Data are presented as ratio of MBP/FITC in FITC-labeled cells from three
independent experiments. n = 4, *P < 0.05, One-way ANOVA with Newman–Keuls post hoc test.
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Fig. S2. (A) Northern blot analysis of RNA isolated from Dicer-ablated mouse brain of indicated lineage: Thy-1 for neurons, PLP for OLs, and GFAP for as-
trocytes. (B) Northern blot analysis of miR-23a transgene with various lengths of flanking sequences in HEK293 cells. The probes used were miR-23a, miR-23b,
and U6 small nuclear (sn)RNA. (C) Schematic diagram of the Cnp–miR-23a construct used in transgenic mouse generation. (D and E) Whole brain samples (D) or
cultured oligodendroglia (E) from WT and Cnp–miR-23a mice were analyzed for miR-23a expression by Northern blot or qRT-PCR of miR-23a.
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Fig. S3. (A) Number of hindlimb footslips, and (B) rate of hindlimb dragging while traversing a 5-mm square balance beam. (C) Measurement of time for Cnp–
miR-23amice to stay on the coat hanger. Filled bars represent Cnp–miR-23a and open bars denote WT mice. Data are presented as ratio of means ± SEM, n = 7
per genotype, **P < 0.01, unpaired Student t test. (D) Expression of OL markers in cells purified from P7 WT and Cnp–miR-23a mice cultured in proliferation
medium followed by qRT-PCR. Data are presented as ratio of means ± SEM, normalized to control, *P < 0.05, **P < 0.01, unpaired Student t test. n = 4 per
genotype. Filled bars represent Cnp–miR-23a OPCs and open bars denote WT OPCs. (E) OPCs purified from P7 WT and Cnp–miR-23a mice cultured for 4 d in
vitro (DIV) in differentiation medium followed by staining for MBP (green), MAG (red), and DAPI (blue). (Scale bar, 50 μm or 10 μm.) (F) Quantitation of
Western blot analyses showed increased expression of PLP and MBP in Cnp–miR-23a OLs relative to control. Protein lysates were purified from OPCs cultured at
4 DIV in differentiation media. GAPDH was used as a loading control. Data were obtained from three independent experiments.
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Fig. S4. Differential transcriptomes of OLs overexpressing miR-23a. (A) Top five physiological functions identified using Ingenuity pathway analysis (IPA) of
total genes. (B) Top five canonical functions containing differentially down-regulated genes identified by using IPA. (C) Differentially expressed genes enriched
in neurons (green), astrocytes (black), or OLs (red). (D) Pie diagram of significantly differentially expressed genes (absolute FC ≥1.5) clustered in neurons,
astrocytes, or OLs. (E) Pie diagram of significantly differentially expressed genes (absolute FC ≥1.5) enriched in oligodendrocyte progenitors (OPC), myelinating
OLs (OL), or the most mature OLs with MOG expression (MOG+ OL). Red indicates up-regulation and blue indicates down-regulation for (D and E).
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Fig. S5. miR-23a regulates PTEN and 2700046G09Rik. (A) Luciferase activity assay in HEK293 overexpressing miR-23a and luciferase constructs carrying ad-
ditional 3′-UTR of targeting candidates. Filled bar denotes luciferase coding sequence without additional 3′-UTR; orange filled bar indicates luciferase with
additional Lmnb1 3′-UTR as a positive control. Data represent means ± SEM, n = 4. TF, transcription factor. (B) Regions of the PTEN and 2700046G09Rik 3′-UTR
with mutated miR-23a–responsive elements (MREs predicted by the TargeScan and miRANDA, in red) were cloned into the luciferase reporter constructs as
depicted. (C) Luciferase activity in HEK293 cotransfected withmiR-23a and reporter constructs containing WT or mutatedmiR-23a binding sites. Data represent
means ± SEM, n = 4, and normalized to the control. *P < 0.05, **P < 0.01 compared with control group; †P < 0.05, ††P < 0.01 compared with WT. One-way
ANOVA with Newman–Keuls post hoc test. (D) Western blot analysis of PTEN from HEK293 coexpressing PTEN coding sequences fused to 2-kb 3′-UTR con-
taining either WT or mutated (Mut) miR-23a binding elements together withmiR-23a as indicated. Quantitative expression levels of PTEN were obtained from
three independent experiments and presented as ratio of means ± SEM, n = 4, and nromalized to control. *P < 0.05, compared with vector control; †P < 0.05
compared with WT; one-way ANOVA with Newman–Keuls post hoc test.
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Fig. S6. (A) Relative RNA levels of 2700046G09Rik in cultured astrocytes, OPC, or OL purified from either C57BL/6 or Cnp–miR-23a mice in differentiation
conditions for 4 d. Data represent means ± SEM, n = 4. *P < 0.05 compared with OPC, †P < 0.05 compared with astrocytes; one-way ANOVA with Newman–
Keuls post hoc test. (B) Representative Western blot analysis is shown of MAG from OPCs overexpressing miR-23a or 2700046G09Rik as indicated.
Fig. S7. miR-23a overexpression leads to activation of Akt/mTOR and MAPK pathways. (A) Western blot analysis of components in the PI3K pathway: p110α,
p110β, p110γ, phosphorylated-p85 (p-p85), phosphorylated p55 (p-p55), and pan-p85 in OPCs purified from wild-type (control) and Cnp–miR-23amice cultured
for 4 DIV in differentiation medium. (B and C) Western blot analysis of p44/p42 MAPK (B) or PKA pathway (phosphorylated PKA and PKA Cα) (C) from OPCs
purified from wild-type (control) or Cnp–miR-23a mice cultured for 4 DIV in differentiation medium.
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Fig. S8. Model for the mechanism of miR-23a in regulating myelination. miR-23a enhances 2700046G09Rik and represses PTEN in oligodendroglia.
2700046G09Rik interacts and stabilizes miR-23a as well as altering its cellular localization, which further enhances repressive effects of miR-23a on PTEN. Less
PTEN in antagonizing PI3K activity leads to AKT activation, which results in myelination. miR-23a represses Lmnb1, leading to increased myelination.
Fig. S9. Up-regulation of miR-23a in the murine model of autosomal dominant adult-onset leuokodystrophy (ADLD). Expression levels of Lmnb1 (A) and
miR-23a (B) in corpus callosum derived from the murine model of ADLD at P360, which is engineered to overexpress Lmnb1. Data represent means ± SEM, n =
4, 6 for control, or Lmnb1BAC per genotype. *P < 0.05, unpaired Student t test.
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